NEW YORK (GenomeWeb News) – Pressure Biosciences said today that it has struck a co-marketing and distribution pact with UK-based Constant Systems that will enable the companies to offer each other's products in North America and Europe.

Under the agreement, Pressure Bio will receive non-exclusive rights to market, sell, and distribute CS's high-pressure cell disruption equipment and consumables in the US, Canada, and Mexico.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.